TW200740802A - Pharmaceutical composition containing thiazolidinedione compound - Google Patents

Pharmaceutical composition containing thiazolidinedione compound

Info

Publication number
TW200740802A
TW200740802A TW095124799A TW95124799A TW200740802A TW 200740802 A TW200740802 A TW 200740802A TW 095124799 A TW095124799 A TW 095124799A TW 95124799 A TW95124799 A TW 95124799A TW 200740802 A TW200740802 A TW 200740802A
Authority
TW
Taiwan
Prior art keywords
pharmaceutical composition
composition containing
thiazolidinedione compound
containing thiazolidinedione
mixture
Prior art date
Application number
TW095124799A
Other languages
English (en)
Inventor
Takao Kawasaki
Nobuyuki Suzuki
Shuichi Yada
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of TW200740802A publication Critical patent/TW200740802A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW095124799A 2005-07-08 2006-07-07 Pharmaceutical composition containing thiazolidinedione compound TW200740802A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005199661 2005-07-08
JP2006013679 2006-01-23

Publications (1)

Publication Number Publication Date
TW200740802A true TW200740802A (en) 2007-11-01

Family

ID=37637049

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095124799A TW200740802A (en) 2005-07-08 2006-07-07 Pharmaceutical composition containing thiazolidinedione compound

Country Status (5)

Country Link
US (1) US20080262054A1 (zh)
EP (1) EP1902713A4 (zh)
JP (1) JPWO2007007656A1 (zh)
TW (1) TW200740802A (zh)
WO (1) WO2007007656A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11241420B2 (en) 2007-04-11 2022-02-08 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
US20160331729A9 (en) 2007-04-11 2016-11-17 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
US8722710B2 (en) 2007-09-26 2014-05-13 Deuterx, Llc Deuterium-enriched pioglitazone
JP6800013B2 (ja) 2013-03-14 2020-12-16 ポクセル・ソシエテ・アノニムＰｏｘｅｌ ＳＡ 重水素化２，４−チアゾリジンジオン及び治療方法
EP3094328B1 (en) 2014-01-15 2020-08-19 Poxel SA Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone
US11319313B2 (en) 2020-06-30 2022-05-03 Poxel Sa Crystalline forms of deuterium-enriched pioglitazone
US11767317B1 (en) 2020-06-30 2023-09-26 Poxel Sa Methods of synthesizing enantiopure deuterium-enriched pioglitazone

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60190723A (ja) * 1984-03-09 1985-09-28 Yamanouchi Pharmaceut Co Ltd 難溶性薬物の溶解速度向上方法
JPH07291854A (ja) * 1994-04-26 1995-11-07 Tanabe Seiyaku Co Ltd 溶解性の改善された医薬品製剤
IL118474A (en) * 1995-06-01 2001-08-08 Sankyo Co Benzimideol derivatives and pharmaceutical preparations containing them
TWI284533B (en) * 1999-05-24 2007-08-01 Sankyo Co Pharmaceutical composition for treating hyperglycemia, impaired glucose tolerance, diabetes complications and for improving insulin resistant
JP2002220336A (ja) * 2000-11-22 2002-08-09 Sankyo Co Ltd 縮合複素環化合物の塩酸塩を含有する糖尿病の予防薬、治療薬
JP2006500377A (ja) * 2002-06-21 2006-01-05 トランスフォーム・ファーマシューティカルズ・インコーポレイテッド 改善された溶解性を有する医薬組成物
TW200637856A (en) * 2005-01-24 2006-11-01 Sankyo Co Process for producing thiazolidinedion compound and intermediate thereof

Also Published As

Publication number Publication date
EP1902713A1 (en) 2008-03-26
WO2007007656A1 (ja) 2007-01-18
US20080262054A1 (en) 2008-10-23
EP1902713A4 (en) 2009-05-13
JPWO2007007656A1 (ja) 2009-01-29

Similar Documents

Publication Publication Date Title
TW200740802A (en) Pharmaceutical composition containing thiazolidinedione compound
WO2007082808A3 (en) Thiazoles as 11 beta-hsd1 inhibitors
GEP20105126B (en) Fused pyrazole derivatives and uses thereof in methods of treatment of metabolic-related disorders
WO2007072163A3 (en) Pyrimidine derivatives
JO2650B1 (en) Solid product
WO2007060140A3 (en) Inhibitors of diacyglycerol acyltransferase (dgat)
RS53638B1 (en) CRYSTAL SOLVATES OF DERIVATIVES (1S) -1,5-ANHYDRO-1-C- (3 - ((PHENYL) METHYL) PHENYL) -D-GLUCITOL WITH ALCOHOLS AS INHIBITORS OF SGLT2 FOR TREATMENT OF DIABETES
NO20092314L (no) Benzamidderivater som EP4 receptoragonister
WO2004037181A3 (en) Glycinenitrile-based inhibitors of dipeptidyl peptidase iv and methods
GB0428514D0 (en) Compounds
EP1714961A4 (en) INDAZOL COMPOUND AND THEIR PHARMACEUTICAL USE
MY143368A (en) Pyrrazolo-pyrimidine derivatives
WO2009010416A3 (en) Inhibitors of 11b-hydroxysteroid dehydrogenase
GEP20084468B (en) Gamma-d crystalline form of ivabradin hydrochloride, process for its preparation and pharmaceutical compositions containing it
WO2005118579A3 (en) Thiazole derivatives as chemokine receptor antagonists
HK1114516A1 (en) Substituted sulfoxide compounds, methods for preparing the same and use thereof
GEP20115138B (en) Benzimidazole derivative and use as angiotensin ii antagonist
NO20072753L (no) 3-Etylidenhydrazinosubstituerte heterocykliske forbindelser som trombopoietinreseptoraktivatorer
WO2007099171A3 (en) Bicyclo-pyrazoles active as kinase inhibitors
MY148529A (en) Formulations of quinolinones
NO20083448L (no) Benzo(f)isoindol-2-ylfenyleddiksyrederivater som EP4 receptoragonister
WO2007018941A3 (en) Pyrimidyl-thiophene derivatives
WO2009109990A3 (en) Pramipexole composition comprising sugar alcohol(s)
WO2007096261A3 (en) Process for the preparation of dioxane derivatives
HK1057751A1 (en) A thiazolidinedione derivative and its use as antidiabetic